Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease ; volume:21 ; number:1 ; day:18 ; month:12 ; year:2024 ; pages:1-24 ; date:12.2024
Journal of neuroinflammation ; 21, Heft 1 (18.12.2024), 1-24, 12.2024

Urheber
Evans, Andrew K.
Park, Heui Hye
Woods, Claire E.
Lam, Rachel K.
Rijsketic, Daniel Ryskamp
Xu, Christine
Chu, Emily K.
Ciari, Peter
Blumenfeld, Sarah
Vidano, Laura M.
Saw, Nay Lui
Heifets, Boris D.
Shamloo, Mehrdad
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12974-024-03306-1
URN
urn:nbn:de:101:1-2503010644547.831578839158
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:37 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Evans, Andrew K.
  • Park, Heui Hye
  • Woods, Claire E.
  • Lam, Rachel K.
  • Rijsketic, Daniel Ryskamp
  • Xu, Christine
  • Chu, Emily K.
  • Ciari, Peter
  • Blumenfeld, Sarah
  • Vidano, Laura M.
  • Saw, Nay Lui
  • Heifets, Boris D.
  • Shamloo, Mehrdad
  • SpringerLink (Online service)

Ähnliche Objekte (12)

BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology

BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology

Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology

Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology

Neuroinflammation increases oxygen extraction in a mouse model of Alzheimer’s disease

Neuroinflammation increases oxygen extraction in a mouse model of Alzheimer’s disease

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer’s disease mouse model

Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer’s disease mouse model

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease

Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease

Neuroinflammation and fractalkine signaling in Alzheimer’s disease

Neuroinflammation and fractalkine signaling in Alzheimer’s disease

α-synuclein in the pathophysiology of Alzheimer’s disease

α-synuclein in the pathophysiology of Alzheimer’s disease

Alzheimer’s disease: natural products as inhibitors of neuroinflammation

Alzheimer’s disease: natural products as inhibitors of neuroinflammation

Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease

Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

Verbundene Objekte